Capital Construction Snapshot: Pharma-Bio Industry to Invest More than $3 Billion in Fourth-Quarter 2012 Project Starts

SUGAR LAND--October 19, 2012--Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas)--With but a scant three months left of 2012, the Pharmaceutical-Biotech Industry is on track to an impressive finish in North America. The sector is set to launch a whopping $3 billion of capital construction and maintenance (MRO) projects during the fourth quarter. That money is targeted for investment in 257 projects, delivering an average total investment value (TIV) of $12 million per project.

Other companies featured: Johnson & Johnson (NYSE:JNJ), Regeneron (NASDAQ:REGN)